These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2543938)

  • 1. [Clinical model concept of the evolution of malignant tumors: implication for hormone therapy of breast cancer].
    Nagel GA; Ammon A; Holtkamp W; Meyer D
    Onkologie; 1989 Apr; 12(2):69-80. PubMed ID: 2543938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro hormone tests in human breast cancers and their relevance for therapy of metastasizing breast cancer].
    Schönfelder M
    Zentralbl Chir; 1987; 112(18):1150-4. PubMed ID: 3687263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen-citrate counteracts the antitumor effects of cytotoxic drugs in vitro.
    Hug V; Hortobagyi GN; Drewinko B; Finders M
    J Clin Oncol; 1985 Dec; 3(12):1672-7. PubMed ID: 4067614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro study of estradiol-linked nitrosourea in breast cancers in the mouse, rat and human: interspecies comparison].
    Petru E; Berger MR; Zeller WJ; Kaufmann M
    Wien Klin Wochenschr; 1989 Feb; 101(4):130-4. PubMed ID: 2538970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug sensitivity testing of gynecologic tumors using Volm's test and stem cell assay].
    Eidtmann H; Jonat W; Maass H
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):477-81. PubMed ID: 4029587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine therapy of breast and prostate cancer.
    Manni A
    Endocrinol Metab Clin North Am; 1989 Jun; 18(2):569-92. PubMed ID: 2663486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal therapy for breast cancer.
    Dunne CF
    Cancer Nurs; 1988 Oct; 11(5):288-94. PubMed ID: 3233579
    [No Abstract]   [Full Text] [Related]  

  • 8. Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin.
    He Q; Liang CH; Lippard SJ
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5768-72. PubMed ID: 10811891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hormonal manipulations in patients with hormone-sensitive metastatic breast cancer.
    Bodmer A; Castiglione-Gertsch M
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S28-37. PubMed ID: 21943985
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
    Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
    Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in growth pattern and drug sensitivity of primary tumor and metastases in the human tumor colony-forming assay.
    Schlag P; Schreml W
    Cancer Res; 1982 Oct; 42(10):4086-9. PubMed ID: 7105006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone dependency of human breast neoplasms cultured in vitro in the stem cell assay.
    Manni A; Wright C; Pontari M; Feil P; Joehl R
    J Natl Cancer Inst; 1985 Apr; 74(4):767-70. PubMed ID: 2985856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the cytostatic effect of epirubicin and mitoxantrone on native breast carcinoma cells using the ATP tumor chemosensitivity assay].
    Kurbacher CM; Brenne U; Kurbacher JA; Mallmann P; Krebs D
    Zentralbl Gynakol; 1996; 118(5):271-8. PubMed ID: 8701623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth of rat mammary adenocarcinoma cells in semisolid clonogenic medium not correlated with spontaneous metastatic behavior: heterogeneity in the metastatic, antigenic, enzymatic, and drug sensitivity properties of cells from different sized colonies.
    Nicolson GL; Lembo TM; Welch DR
    Cancer Res; 1988 Jan; 48(2):399-404. PubMed ID: 2825974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone-resistant breast cancer or "feeding the hand that bites you".
    Horwitz KB
    Prog Clin Biol Res; 1994; 387():29-45. PubMed ID: 7972253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormone dependence of malignant ovarian tumors--an in vitro model].
    Schieder K; Bieglmayer C; Kölbl H
    Geburtshilfe Frauenheilkd; 1989 May; 49(5):437-41. PubMed ID: 2544477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase.
    Bitonti AJ; Dumont JA; Bush TL; Cashman EA; Cross-Doersen DE; Wright PS; Matthews DP; McCarthy JR; Kaplan DA
    Cancer Res; 1994 Mar; 54(6):1485-90. PubMed ID: 8137252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormonal regulation in breast cancer from cell lines to patients].
    Rochefort H
    Presse Med; 1994 Sep 3-10; 23(26):1211-6. PubMed ID: 7831215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colony formation in vitro as a prognostic indicator for primary breast cancer.
    Aapro MS; Eliason JF; Krauer F; Alberto P
    J Clin Oncol; 1987 Jun; 5(6):890-6. PubMed ID: 3035110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of the adenosine triphosphate chemosensitivity assay for pre-therapeutic determination of the chemosensitivity of breast cancer cells in cell culture].
    Köchli OR; Sevin BU; Schär G; Haller U
    Geburtshilfe Frauenheilkd; 1995 Jan; 55(1):7-16. PubMed ID: 7705600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.